2nd Annual Breast Cancer Symposium

September 25, 2020 to September 26, 2020
Advances in breast cancer health have been growing exponentially during the twenty-first century and identification of novel therapeutic strategies have led to improved surgical and radiation outcomes. Actionable targets have identified smarter systemic therapies with improved, disease-free, overall survival benefits. In addition to awareness, addressing the health, emotional, and physical well-being of patients after breast cancer treatment have improved the overall quality of life for the patient and their families. As breast cancer is a multimodal disease, the purpose of this conference is to present the multiple facets that constitute the individual patient’s diagnosis, management, and treatment. The goal of this conference is to educate the medical and global community in a forum to foster communication that will benefit the individual patient as well as the community.

More information about the program and registration can be found here!

Target Audience

This activity is intended for medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast cancer are invited to attend.

Learning Objectives

At the conclusion of this activity, participants will be able to:
 
  • Review the modern surgical approaches addressed in the patient encounter;
  • Discuss updates in breast cancer imaging for earlier detection;
  • Identify therapeutic advances in early and advanced hormone receptor-positive, HER2neu overexpressing and triple negative breast cancer;
  • Review advances in radiation therapy and outcomes;
  • Identify risk factors and endocrine interventions in patients high risk for developing breast cancer;
  • Discuss the role of hereditary genetics and the implication to the patient and their families.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
Professionalism
For more information, please contact:
CME Coordinator Contact Name: 
MyMedEd
CME Coordinator Contact Email: 
Summary
Available credit: 
  • 11.00 AMA PRA Category 1 Credit™
  • 11.00 Participation
Event starts: 
09/25/2020 - 12:00pm
Event ends: 
09/26/2020 - 2:10pm
Activity opens: 
09/02/2020
Activity expires: 
12/02/2020
Webinar
Albany, NY
United States
WANT TO KNOW MORE?
Learn more about the Breast Cancer Symposium here!
 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact MyMedEd via email at BCS@mymededco.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

COURSE CHAIR AND MODERATOR
  Maria Theodoulou, MD
  New York Oncology Hematology
 
 
 
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 11 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
 
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
Registration: Click below for more information or to get registered!
 
Please login or create an account to proceed.